glp-1 alzheimer's disease drugs failed to slow in two big clinical trials ๐ ๐๐๐ฎ๐ซ๐จ๐ฉ๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ข๐ฌ๐ญ'๐ฌ ๐๐๐ค๐ ๐จ๐ง ๐๐๐-๐๐ฌ
Description
The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era
Requiring so many manual steps before using an emergency device is []
Learn how to manage it during your weight loss journey.
The largest prescription growth area in the last year for state employees and retirees was for weight loss drugs
